Page last updated: 2024-12-07

thiophene a

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

thiophene A: RN not in Chemline 4/87; RN from Chem Abstracts Index Guide 1986; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID100448
SCHEMBL ID22733849
MeSH IDM0147173

Synonyms (19)

Synonym
thiophene a
nsc-302303
nsc302303
2134-99-8
bohlmann k4018
2-hex-5-en-1,3-diynyl-5-prop-1-ynylthiophene
y5ixf40lug ,
thiophene-a
nsc 302303
thiophene, 2-(5-hexene-1,3-diynyl)-5-(1-propynyl)-
unii-y5ixf40lug
DTXSID20175608
2-(hexa-5-en-1,3-diyn-1-yl)-5-(prop-1-yn-1-yl)thiophene
LMFA12000347
2-(hexa-5-en-1,3-diynyl)-5-(propynyl)-thiophene
thiophene, 2-(5-hexene-1,3-diyn-1-yl)-5-(1-propyn-1-yl)-
2-(5-hexene-1,3-diyn-1-yl)-5-(1-propyn-1-yl)thiophene
thiophene, 2-(5-hexen-1,3-diynyl)-5-(1-propynyl)-
SCHEMBL22733849
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (9)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (22.22)18.7374
1990's0 (0.00)18.2507
2000's2 (22.22)29.6817
2010's5 (55.56)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.30

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.30 (24.57)
Research Supply Index2.40 (2.92)
Research Growth Index4.70 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.30)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies1 (10.00%)4.05%
Observational0 (0.00%)0.25%
Other9 (90.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]